Revive Therapeutics
(OTC) RVVTF
Revive Therapeutics Financials at a Glance
Market Cap
$14.74M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.69M
EPS (TTM)
$-0.02
P/E Ratio
-1.92
Dividend
$0.00
Beta (Volatility)
-0.06 (Low)
Dividend
$0.00
Beta (Volatility)
-0.06 (Low)
Price
$0.03
Volume
1,243,265
Open
$0.03
Price
$0.03
Volume
1,243,265
Open
$0.03
Previous Close
$0.03
Daily Range
$0.02 - $0.03
52-Week Range
$0.01 - $0.06
Dividend
$0.00
Beta (Volatility)
-0.06 (Low)
Price
$0.03
Volume
1,243,265
Open
$0.03
Previous Close
$0.03
Daily Range
$0.02 - $0.03
52-Week Range
$0.01 - $0.06
RVVTF News
RVVTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Revive Therapeutics
Industry
Pharmaceuticals
Sector
Health CareCEO
Michael Frank
Website
www.revivethera.comHeadquarters
Toronto, ON M5C 1P1, CA
RVVTF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-897%
Return on Capital
37%
Return on Assets
-41%
Earnings Yield
-52.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.74M
Shares Outstanding
418.56M
Volume
1.24M
Short Interest
0.00%
Avg. Volume
624.10K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.65M
EBITDA
$11.01M
Operating Cash Flow
$767.66K
Capital Expenditure
$0.00
Free Cash Flow
$767.66K
Cash & ST Invst.
$14.56K
Total Debt
$66.87K
Revive Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$47.96
N/A
Gross Margin
0.00%
N/A
Market Cap
$14.74M
N/A
Market Cap/Employee
$4.91M
N/A
Employees
3
N/A
Net Income
$238.53K
+34.6%
EBITDA
$280.21K
+23.2%
Quarterly Fundamentals
Net Cash
$46.57K
-184.0%
Accounts Receivable
$39.38K
+5502.0%
Inventory
$0.00
N/A
Long Term Debt
$69.43K
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-40.92%
N/A
Return on Invested Capital
36.60%
N/A
Free Cash Flow
$142.41K
+69.7%
Operating Cash Flow
$142.41K
+69.7%